Preparation of genetically or chemically engineered exosomes and their therapeutic effects in bone regeneration and anti-inflammation
Open Access
- 19 January 2024
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 12, 1329388
Abstract
The treatment of bone or cartilage damage and inflammation-related diseases has been a long-standing research hotspot. Traditional treatments such as surgery and cell therapy have only displayed limited efficacy because they can’t avoid potential deterioration and ensure cell activity. Recently, exosomes have become a favorable tool for various tissue reconstruction due to their abundant content of proteins, lipids, DNA, RNA and other substances, which can promote bone regeneration through osteogenesis, angiogenesis and inflammation modulation. Besides, exosomes are also promising delivery systems because of stability in the bloodstream, immune stealth capacity, intrinsic cell-targeting property and outstanding intracellular communication. Despite having great potential in therapeutic delivery, exosomes still show some limitations in clinical studies, such as inefficient targeting ability, low yield and unsatisfactory therapeutic effects. In order to overcome the shortcomings, increasing studies have prepared genetically or chemically engineered exosomes to improve their properties. This review focuses on different methods of preparing genetically or chemically engineered exosomes and the therapeutic effects of engineering exosomes in bone regeneration and anti-inflammation, thereby providing some references for future applications of engineering exosomes.Keywords
This publication has 182 references indexed in Scilit:
- MicroRNA control of bone formation and homeostasisNature Reviews Endocrinology, 2012
- Risk factors in the development of stem cell therapyJournal of Translational Medicine, 2011
- Delivery of siRNA to the mouse brain by systemic injection of targeted exosomesNature Biotechnology, 2011
- The Role of NELL-1, a Growth Factor Associated with Craniosynostosis, in Promoting Bone RegenerationJournal of Dental Research, 2010
- Targeted Intracellular Delivery of Antisense Oligonucleotides via Conjugation with Small-Molecule LigandsJournal of the American Chemical Society, 2010
- Functional delivery of viral miRNAs via exosomesProceedings of the National Academy of Sciences, 2010
- Cellular Internalization of Exosomes Occurs Through PhagocytosisTraffic, 2010
- Developments in the clinical understanding of osteoarthritisArthritis Research & Therapy, 2009
- Biomimetic amplification of nanoparticle homing to tumorsProceedings of the National Academy of Sciences, 2007
- Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts.Journal of Clinical Investigation, 1998